Speaker Profile
Hui Li

Hui Li BS, PhD

Oncology, Pharmacy and Medicine
San Diego, California, United States of America

Connect with the speaker?

Dr Hui Li joined Levena BioPharma as CEO in April 2015. From 2010 to 2015, he served as an Executive Director of Business Development at PPD/BioDuro, where he was responsible from business strategy formulation to collaboration and partnership establishment. Prior to joining PPD/BioDuro, Dr. Li spent 10 years at Pfizer Global Research & Development, La Jolla Laboratories and has led research programs in a number of disease areas including oncology, metabolic diseases, anti-viral, and ophthalmology. He is an inventor of Filibuvir (PF-00868554), an HCV polymerase inhibitor currently in phase II clinical trials by Pfizer and MS-553, a PKC  inhibitor currently in phase I clinical trials by Mingsight. Dr. Li obtained his bachelor degree in chemistry from Peking University and Ph.D in chemistry from University of California, San Diego.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)